BACKGROUND: Host genetic variation influences human immunodeficiency virus (HIV) infection and progression to AIDS. Here we used clinically well-characterized subjects from 5 pretreatment HIV/AIDS cohorts for a genome-wide association study to identify gene associations with rate of AIDS progression. METHODS: European American HIV seroconverters (n = 755) were interrogated for single-nucleotide polymorphisms (SNPs) (n = 700,022) associated with progression to AIDS 1987 (Cox proportional hazards regression analysis, co-dominant model). RESULTS: Association with slower progression was observed for SNPs in the gene PARD3B. One of these, rs11884476, reached genome-wide significance (relative hazard = 0.3; P =3. 370 × 10(-9)) after statistical correction for 700,022 SNPs and contributes 4.52% of the overall variance in AIDS progression in this study. Nine of the top-ranked SNPs define a PARD3B haplotype that also displays significant association with progression to AIDS (hazard ratio, 0.3; P = 3.220 × 10(-8)). One of these SNPs, rs10185378, is a predicted exonic splicing enhancer; significant alteration in the expression profile of PARD3B splicing transcripts was observed in B cell lines with alternate rs10185378 genotypes. This SNP was typed in European cohorts of rapid progressors and was found to be protective for AIDS 1993 definition (odds ratio, 0.43, P = .025). CONCLUSIONS: These observations suggest a potential unsuspected pathway of host genetic influence on the dynamics of AIDS progression.
BACKGROUND: Host genetic variation influences human immunodeficiency virus (HIV) infection and progression to AIDS. Here we used clinically well-characterized subjects from 5 pretreatment HIV/AIDS cohorts for a genome-wide association study to identify gene associations with rate of AIDS progression. METHODS: European American HIV seroconverters (n = 755) were interrogated for single-nucleotide polymorphisms (SNPs) (n = 700,022) associated with progression to AIDS 1987 (Cox proportional hazards regression analysis, co-dominant model). RESULTS: Association with slower progression was observed for SNPs in the gene PARD3B. One of these, rs11884476, reached genome-wide significance (relative hazard = 0.3; P =3. 370 × 10(-9)) after statistical correction for 700,022 SNPs and contributes 4.52% of the overall variance in AIDS progression in this study. Nine of the top-ranked SNPs define a PARD3B haplotype that also displays significant association with progression to AIDS (hazard ratio, 0.3; P = 3.220 × 10(-8)). One of these SNPs, rs10185378, is a predicted exonic splicing enhancer; significant alteration in the expression profile of PARD3B splicing transcripts was observed in B cell lines with alternate rs10185378 genotypes. This SNP was typed in European cohorts of rapid progressors and was found to be protective for AIDS 1993 definition (odds ratio, 0.43, P = .025). CONCLUSIONS: These observations suggest a potential unsuspected pathway of host genetic influence on the dynamics of AIDS progression.
Authors: Edione C Reis; Lais T da Silva; Wanessa C da Silva; Alexandre Rios; Alberto J Duarte; Telma M Oshiro; Sergio Crovella; Alessandra Pontillo Journal: Hum Vaccin Immunother Date: 2018-05-17 Impact factor: 3.452
Authors: Wen Xie; Denis Agniel; Andrey Shevchenko; Sergey V Malov; Anton Svitin; Nikolay Cherkasov; Marianna K Baum; Adriana Campa; Simani Gaseitsiwe; Hermann Bussmann; Joseph Makhema; Richard Marlink; Vladimir Novitsky; Tun-Hou Lee; Tianxi Cai; Stephen J O'Brien; M Essex Journal: AIDS Res Hum Retroviruses Date: 2017-04-06 Impact factor: 2.205
Authors: Hafiza Fizzah Zulfiqar; Aneeqa Javed; Bakht Afroze; Qurban Ali; Khadija Akbar; Tariq Nadeem; Muhammad Adeel Rana; Zaheer Ahmad Nazar; Idrees Ahmad Nasir; Tayyab Husnain Journal: Front Public Health Date: 2017-03-07
Authors: Virginia Perez-Andreu; Kathryn G Roberts; Heng Xu; Colton Smith; Hui Zhang; Wenjian Yang; Richard C Harvey; Debbie Payne-Turner; Meenakshi Devidas; I-Ming Cheng; William L Carroll; Nyla A Heerema; Andrew J Carroll; Elizabeth A Raetz; Julie M Gastier-Foster; Guido Marcucci; Clara D Bloomfield; Krzysztof Mrózek; Jessica Kohlschmidt; Wendy Stock; Steven M Kornblau; Marina Konopleva; Elisabeth Paietta; Jacob M Rowe; Selina M Luger; Martin S Tallman; Michael Dean; Esteban G Burchard; Dara G Torgerson; Feng Yue; Yanli Wang; Ching-Hon Pui; Sima Jeha; Mary V Relling; William E Evans; Daniela S Gerhard; Mignon L Loh; Cheryl L Willman; Stephen P Hunger; Charles G Mullighan; Jun J Yang Journal: Blood Date: 2014-12-02 Impact factor: 22.113
Authors: Sher L Hendrickson; James A Lautenberger; Leslie Wei Chinn; Michael Malasky; Efe Sezgin; Lawrence A Kingsley; James J Goedert; Gregory D Kirk; Edward D Gomperts; Susan P Buchbinder; Jennifer L Troyer; Stephen J O'Brien Journal: PLoS One Date: 2010-09-21 Impact factor: 3.240
Authors: Heng Xu; Wenjian Yang; Virginia Perez-Andreu; Meenakshi Devidas; Yiping Fan; Cheng Cheng; Deqing Pei; Paul Scheet; Esteban González Burchard; Celeste Eng; Scott Huntsman; Dara G Torgerson; Michael Dean; Naomi J Winick; Paul L Martin; Bruce M Camitta; W Paul Bowman; Cheryl L Willman; William L Carroll; Charles G Mullighan; Deepa Bhojwani; Stephen P Hunger; Ching-Hon Pui; William E Evans; Mary V Relling; Mignon L Loh; Jun J Yang Journal: J Natl Cancer Inst Date: 2013-03-19 Impact factor: 13.506
Authors: Paul J McLaren; Cedric Coulonges; István Bartha; Tobias L Lenz; Aaron J Deutsch; Arman Bashirova; Susan Buchbinder; Mary N Carrington; Andrea Cossarizza; Judith Dalmau; Andrea De Luca; James J Goedert; Deepti Gurdasani; David W Haas; Joshua T Herbeck; Eric O Johnson; Gregory D Kirk; Olivier Lambotte; Ma Luo; Simon Mallal; Daniëlle van Manen; Javier Martinez-Picado; Laurence Meyer; José M Miro; James I Mullins; Niels Obel; Guido Poli; Manjinder S Sandhu; Hanneke Schuitemaker; Patrick R Shea; Ioannis Theodorou; Bruce D Walker; Amy C Weintrob; Cheryl A Winkler; Steven M Wolinsky; Soumya Raychaudhuri; David B Goldstein; Amalio Telenti; Paul I W de Bakker; Jean-François Zagury; Jacques Fellay Journal: Proc Natl Acad Sci U S A Date: 2015-11-09 Impact factor: 11.205